Endocrinology Flashcards
In what conditions can you not use HbA1C to diagnose T2DM?
Haemoglobinopathies
Haemolytic anaemia
Untreated iron deficiency anaemia
Gestational diabetes
Children
HIV
CKD
Medications causing hyperglycaemia
Alterations to metformin dose during ramadan
split dose to 1/3rd before sunrise and 2/3rds after sunset
Alteration to sulfonyulrea dose during ramadan
OD - take after sunset
BD - take large proportion after sunset
Dietary advice for T2DM during ramadan
Meal containing long acting carbohydrates prior to sunrise
Sick day rules for diabetes
Four hourly BMs
3 litres of fluid
May need sugary fluids if can’t drink
Continue normal insulin
Stop metformin if dehydrated
Continue oral hypoglycaemic meds
Conditions that need to be met to hold HGV licence if diabetic
No severe hypo in 12 months
Full hypo awareness
Adequate control shown by regular BMs
Understands risks of hypos
No other debarring conditions from diabetes
Conditions that need to be met to hold group 1 license if diabetic on insulin
Hypoglycaemic awareness
No hypo needing help in last 12 months
No relevant visual impairment
What is the target when treating hyperlipidaemia?
40% reduction in non-HDL cholesterol
Pre-diabetes range for HbA1c in mmol/mol
42-47
Non-drug causes of gynaecomastia
Physiological - normal in puberty
Androgen deficiency syndromes (Kallman, Klinefelters)
Testicular failure
Liver disease
Testicular cancer
Ectopic tumour secretion
Hyperthyroidism
Haemodialysis
Drug causes of gynaecomastia
Spironolactone
Cimetidine
Digoxin
Cannabis
Finasteride
GnRH agonists - goserelin, buserelin
Oestrogens, anabolic steroids
Orlistat - mechanism of action
Pancreatic lipase inhibitor
Orlistat - side effects
Faecal urgency
Incontinence
Flatulence
Criteria for starting orlistat
BMI over 28 with associated risk factors
BMI over 30
Criteria for continuing orlistat
Continued weight loss - 5% at 3 months
How long is orlistat used for?
1 year
TFTs in secondary hypothyroidism
Low TSH
Low T4
Investigations for secondary hypothyroidism
MRI pituitary
Cause of secondary hypothyroidism
Pituitary insufficiency
First line insulin regime for new T1DM
Basal bolus with twice daily insulin detemir
Pre-diabetes range for HbA1c in %
6.0-6.4%
Possible consequences of untreated subclinical hyperthyroidism
Supraventricular arrhythmias and osteoporosis
When do patients require a gradual withdrawal of systemic corticosteroids?
> 40mg pred daily for >1 week
> 3 weeks treatment
Recently received repeated courses
What ketones should prompt admission to hospital in T1DM?
3
Medication that interacts with orlistat
Contraception and anti-epileptics
due to GI side effects affecting absorption
At what renal function should you review metformin?
At what renal function should you stop stop metformin?
Review at creat >130 or eGFR <45
Stop if creat >150 or eGFR <30
Should you ever start metformin in prediabetes?
Yes if HbA1c going up despite lifestyle measures
Extra investigations for new T2DM diagnosed over age 60 or weight loss
CT abdomen to exclude pancreatic ca
Blood glucose targets in T1DM - on waking
5-7 mmol/l
Blood glucose targets in T1DM - before meals during the day
4-7 mmol/l
Which group of patients taking insulin do not need to inform DVLA?
Taking insulin for less than 3 months
Taking for gestational diabetes up to 3 months post partum
Which type of drugs reduced hypoglycaemia awareness?
Beta blockers
TSH goal in treating hypothyroidism
0.5 to 2.5 mU/l
Instructions to patients on how to take levothyroxine
30 minutes before breakfast or caffeine or other medication
Blood pressure target in T1DM with no end organ damage
135/85
Blood pressure target in T1Dm if albuminuria or 2 or more features of metabolic syndrome
130/80
Criteria for diagnosing T1DM
Fasting glucose ≥ 7
Random glucose ≥ 11.1
If not symptomatic needs to be on two occasions
Target HbA1c in T1DM
≤48
T1DM investigations
Urine dip
Fasting + random glucose
C-peptide
Anti-glutamic acid antibodies (anti-GAD)
Islet cell antibodies
Insulin autoantibodies
Insulinoma-associated-2 autoantibodies
Tests to do when differentiating between T1 and T2 diabetes
C-peptide
Insulin antibodies
What are the insulin antibodies to test for?
Anti-glutamic acid antibodies
Islet cell antibodies
Insulin autoantibodies
Insulinoma-associated-2 autoantibodies
HbA1c target for T2DM being managed with lifestyle measures
48
HbA1c target for T2DM being managed with lifestyle measures and metformin
48
HbA1c target for T2DM being managed with any drug that can cause hypoglycaemia
53
At what HbA1c do you add a second medication to metformin?
58
At what HbA1c do you start metformin?
48
2nd line medication options to add to metformin in the management of T2DM
Sulfonylurea
Gliptin
Pioglitazone
SGLT2 inhibitor
3rd line medication options to add to metformin in managmeent of T2DM
Sulfonylurea
Gliptin
Pioglitazone
SGLT2 inhibitor
OR consider insulin
Which medication should you continue when starting insulin in T2DM?
Metformin only
Medication options for T2DM who can’t tolerate metformin
Sulfonylurea
Gliptin
Pioglitazone
Start with 1, add 2nd if HbA1c ≥ 58
When to consider insulin in T2DM who can’t tolerate metformin?
After 2 drugs started and HbA1c rising to ≥ 58 or remains high
Dietary advice in T2DM
High fibre low GI carbs
Low fat dairy products
Oily fish
Reduce saturated fats + trans fats
Discourage diabetic foods
Target weight loss in T2DM
5-10%
Even if normal weight
When to start cholesterol medication in T2DM?
If 10 year cardiovascular risk score is >10% using QRISK 2
Primary prevention statin
Atorvastatin 20mg
Secondary prevention statin
Atorvastatin 80mg
BP targets in T2DM if age <80
clinic 140/90
ABPM 135/85
BP targets in T2DM if age >80
clinic 150/90
ABPM 145/85
First line treatment for hypertension in T2DM
ACEI or ARB
Use ARB if black/Caribbean
What will cause a lower than expected HbA1c?
Reduced red cell lifespan due to
- sickle cell anaemia
- GP6D deficiency
- hereditary spherocytosis
What will cause a higher than expected HbA1c?
Increased red cell lifespan due to
- Vit B12/folate acid deficiency
- iron deficiency anaemia
- splenectomy
Examples of SGLT-2 inhibitors
Canagliflozin
Dapagliflozin
Empagliflozin
What type of drug is canagliflozin?
SGLT2 inhibitor
What type of drug is dapagliflozin?
SGLT2 inhibitor
What type of drug is empagliflozin?
SGLT2 inhibitor
Mechanism of action of SGLT-2 inhibitors
Reversibly inhibit sodium-glucose cotransporter 2 in the renal PCT
to reduce glucose reabsorption and increase urinary glucose excretion
Side effects of SGLT-2 inhibitors
Urinary and genital infections
Fournier’s gangrene
Normoglycaemic ketoacidosis
Increased risk of lower limb amputation so need to monitor feet carefully
Examples of sulfonylureas
Gliclazide
Tolbutamide
What type of drug is gliclazide?
Sulfonylurea
What type of drug is tolbutamide?
Sulfonyulrea
Effect of SGLT-2 inhibitors on weight
Weight loss
Do SGLT-2 inhibitors cause hypoglycaemia?
Not by themselves
Mechanism of action of sulfonylureas
Increase pancreatic insulin secretion
Where in the pancreas do sulfonylureas work?
ATP dependent K+ channels on the cell membrane of pancreatic beta cells
to increase pancreatic insulin secretion
Side effects of sulfonylureas
Hypoglycaemia
Weight gain
SIADH
Bone marrow suppression
Cholestatic liver damage
Peripheral neuropathy
Effect of sulfonylureas on weight
Weight gain
Do sulfonylureas cause hypoglycaemia?
Yes
Which T2DM medication can cause liver damage?
Sulfonylureas cause cholestatic liver damage
Pioglitazone causes liver impairment, need to monitor LFTs
Example of thiazolidinediones
Pioglitazone
What type of drug is pioglitazone?
Thiazolidinedione
Mechanism of action of pioglitazone
Reduces peripheral insulin resistance
by agonising the PPAR-gamma receptor
Which T2DM medication reduces peripheral insulin resistance?
Pioglitazone
Side effects of pioglitazone
Weight gain
Liver impairment
Fluid retention so C/I in heart failure
Increased risk of fractures
Increased risk of bladder ca
Effect of pioglitazone on weight
Weight gain
Can pioglitazone cause hypoglycaemia?
Not when taken in isolation
Examples of meglitinides
Repaglinide
Nateglinide
What type of medication is repaglinide?
meglitinide, used in T2DM
What type of medication is nateglinide?
Meglitinide, used in T2DM
For which group of patients are meglitinides helpful?
Those with erratic lifestyles
Mechanism of action of meglitinides
Increase pancreatic insulin secretion
Side effects of meglitinides
Weight gain
Hypoglycaemia
Examples of rapid acting insulins
Aspart (novorapid)
Lispro (humalog)
Examples of short acting insulins
Actrapid
Humulin S
Examples of intermediate acting insulins
Isophane
Aspart protamine
lispro protamine
Examples of long acting insulins
Detemir (levemir)
Glargine (lantus)
Examples of GLP-1 mimics
Exenatide
Liraglutide
What type of drug is exenatide?
GLP-1 mimic
How is exenatide taken?
sub cut 60 minutes before morning and evening meal
How is liraglutide taken?
sub cut once daily
What type of drug is liraglutide?
GLP-1 mimic
Mechanism of action of GLP-1 mimics
Increase insulin secretion and inhibit glucagon secretion
Side effects of GLP-1 mimics
Nausea and vomiting
Renal impairment
Severe pancreatitis
Criteria for starting GLP-1 mimics
Triple therapy not effective AND one of:
BMI ≥ 35 + obesity related health problems
BMI <35 + insulin would cause occupational problems + weight related health conditions
Criteria for continuing GLP-1 mimics
Drop of 11 mmol/mol (1%) in HbA1c AND weight loss of 3% in 6 months
Effect of GLP-1 mimics on weight
Weight loss
Do GLP-1 mimics cause hypoglycaemia?
Not in isolation
Examples of DPP-4 inhibitors
Vildagliptin
Sitagliptin
What type of drug is vildagliptin?
DPP-4 inhibitor
What type of drug is sitagliptin?
DPP-4 inhibitor
What drug classification is generally referred to as gliptins?
DPP-4 inhibitors
Examples of gliptins
Vildagliptin
Sitagliptin
Mechanism of action of DPP-4 inhibitors/gliptins
Increase levels of incretins (GLP1 and GIP) by decreasing their peripheral breakdown
How are DPP-4 inhibitors/gliptins taken?
Orally
Impact of DPP-4 inhibitors/gliptins on weight
Weight neutral
Do DPP-4 inhibitors cause hypoglycaemia?
No
Two key causes of diabetic foot disease
Neuropathy
Peripheral artery disease
Screening for diabetic foot disease
Every year
Check for ischaemia by palpating pulses
Check for neuropathy using a 10g monofilament
Presentation of diabetic foot disease
Neuropathy
Ischaemia - absent foot pulses, intermittent claudication
Calluses
Ulceration
Charcot’s arthropathy
Cellulitis
Osteomyelitis
Gangrene
Diabetic foot disease - low risk
No risk factors except callus
Diabetic foot disease - moderate risk
1 of:
Deformity
Neuropathy
Non-critical limb ischaemia
Diabetic foot disease - high risk
Previous ulceration or amputation
on RRT
2 of: deformity, neuropathy, non-critical limb ischaemia